CD22 (Pan B Cell Marker)

image not found

NABL Cap Accredited 
The Orange Healthcare CD22 (Pan B Cell Marker) Test is a specialised diagnostic investigation used to detect CD22, a cell-surface protein primarily expressed on mature B lymphocytes and certain stages of B-cell development. CD22 plays an important role in regulating B-cell activation and immune responses. The Orange Healthcare CD22 (Pan B Cell Marker) Test helps identify B-cell populations and supports the diagnosis and classification of B-cell leukaemias, lymphomas, and other lymphoproliferative disorders. Abnormal CD22 expression may provide information about the characteristics of malignant or atypical B cells. Results should be interpreted alongside other immunophenotypic markers, tissue morphology, clinical findings, and relevant laboratory investigations.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,750.00 Rs. 4,875.00

23% OFF

Sample Type: Blood

Fasting Not Required


Booking Procedure:
  1. Select your preferred Orange Health test or package on BookMyTest and complete your booking with your details.
  2. Pick a convenient time slot. A trained eMedic will be assigned and can reach you within 60 minutes of booking or at your scheduled time.
  3. At your selected time, a trained eMedic will visit your doorstep for safe and hygienic sample collection using a painless single-prick method. Samples are securely stored and transported to certified labs for processing.
  4. Doctor-verified reports are shared via WhatsApp, email, and the Orange Health app. You can also access them anytime from your registered account.

Frequently Asked Questions (FAQ's):

1. What is the Orange Healthcare CD22 (Pan B Cell Marker) Test?
It is a specialised laboratory test used to detect CD22 protein expression on B lymphocytes, helping identify B-cell populations and characterise certain blood and lymphatic system disorders.

2. Why is the CD22 (Pan B Cell Marker) Test performed?
The test is performed to support the diagnosis and classification of B-cell leukaemias, lymphomas, and other lymphoproliferative disorders. It may also help assess CD22 expression when considering certain targeted treatments.

3. What does a positive CD22 result indicate?
A positive result indicates CD22 expression in the examined cells and generally supports B-cell lineage. CD22 positivity may be observed in normal B lymphocytes and various B-cell malignancies, so it does not independently confirm cancer.

4. What does a negative CD22 result indicate?
A negative result indicates that CD22 expression was not detected in the examined cell population. Reduced or absent expression may occur in certain B-cell malignancies or during specific stages of B-cell differentiation. Further immunophenotypic evaluation may be necessary.

5. Is fasting required for the Orange Healthcare CD22 (Pan B Cell Marker) Test?
Fasting is generally not required. However, if the test involves a biopsy, bone marrow aspiration, or another invasive procedure, patients should follow the preparation instructions provided by their healthcare team.

6. What sample is required for the CD22 (Pan B Cell Marker) Test?
The required specimen depends on the clinical indication and testing method. Tissue biopsy samples may be examined using immunohistochemistry, while peripheral blood, bone marrow aspirates, or fresh tissue specimens may be analysed using flow cytometry to detect CD22 expression.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab